课题基金 / 基金详情

REGULATION OF THE EBV LYTIC SWITCH GENE BZLF1

REGULATION OF THE EBV LYTIC SWITCH GENE BZLF1
EBV 裂解开关基因 BZLF1 的调控
批准号:
2517116
负责人:
KAREN E WECK
金额:
$9.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 1998-08-31

项目摘要

项目成果

KAREN E WECK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epstein-Barr virus (EBV) is a human lymphotropic herpesvirus which is the etiologic agent of infectious mononucleosis, and is closely associated with the development of several human cancers. Like Other herpesviruses, EBV can establish either a lytic or latent infection. The proposed research involves characterizing the regulation of the EBV lytic cycle gene BZLF1, which has been shown to be important for induction of the entire lytic cascade. The long-term objectives of these studies are to understand the mechanisms whereby induction of the lytic cycle of EBV is controlled in vivo, and the importance of these mechanisms to viral survival in the host. Proper regulation of lytic induction is likely to be important both for cell-to-cell spread and for immortalization of EBV infected cells. The specific aims of this proposal are 1) Analysis of selected BZLF1 promoter and gene mutations within the context of the viral genome. Selected mutations will be made by homologous recombination, and the effects on induction of the lytic cycle, the formation of immortalized cell lines, and infectivity will be studied. 2) Characterization of the efficiency of induction of the BZLF1 gene in latently infected cells. In situ techniques will be used to compare expression of the BZLF1 gene product with other lytic antigens and with cellular inducible genes to determine whether induction of the lytic cycle is blocked specifically at BZLF1 gene expression. The applicant has developed this proposal with an objective to become an established, independent investigator of the Epstein-Barr virus. The applicant will devote 100% effort to the proposed research for the duration of this award, in order to maximize the potential to realize this objective. The sponsor's laboratory was chosen on the basis of scientific merit, enthusiasm, knowledge of EBV, availability of resources, and dedication to the applicant; in addition there is a strong Community of virologists and immunologists at this institution whose expertise will be invaluable to the applicant's scientific development.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.
鼠伽马疱疹病毒 68 在缺乏干扰素伽马反应性的小鼠中引起严重的大血管动脉炎:病毒诱发的血管疾病的新模型。
DOI: 10.1038/nm1297-1346
发表时间: 1997
期刊: Nature medicine
影响因子: 82.9
作者: [Weck,KE, DalCanto,AJ, Gould,JD, O'Guin,AK, Roth,KA, Saffitz,JE, Speck,SH, Virgin,HW]
通讯作者: Virgin,HW
REGULATION OF THE EBV LYTIC SWITCH GENE BZLF1
  • 批准号:
    2057522
  • 项目类别:
  • 资助金额:
    $8.78万
  • 财政年份:
    1995
  • 负责人:
    KAREN E WECK
  • 依托单位:
REGULATION OF THE EBV LYTIC SWITCH GENE BZLF1
  • 批准号:
    2057521
  • 项目类别:
  • 资助金额:
    $8.49万
  • 财政年份:
    1995
  • 负责人:
    KAREN E WECK
  • 依托单位:
TRANSCRIPTIONAL REGULATION OF NGFI-A
  • 批准号:
    3055894
  • 项目类别:
  • 资助金额:
    $2.99万
  • 财政年份:
    1992
  • 负责人:
    KAREN E WECK
  • 依托单位:
TRANSCRIPTIONAL REGULATION OF NGFI-A
  • 批准号:
    3055893
  • 项目类别:
  • 资助金额:
    $2.8万
  • 财政年份:
    1991
  • 负责人:
    KAREN E WECK
  • 依托单位:
海外基金